Pharmaceutical/Biotech

Think Tank

Additive Manufacturing and the Supply Chain: Opportunities and Risks

October 17, 2018

Ilan Solel

Many supply-chain headaches can be alleviated with 3-D printing, but there are some perils attached to the benefits.

Think Tank

The Science of ‘Fingerprinting’ Products in the Supply Chain

October 15, 2018

Robert J. Bowman, SupplyChainBrain

The term “forensic science” conjures up images of police dramas and crime investigations. But it turns out to have a strong connection to global supply chains, too.

Nafta by Any Other Name Is Just Fine With Corporate America

October 4, 2018

Bloomberg

The sky isn’t falling. That’s the message coming from Corporate America after President Trump reached a deal to revise the North American Free Trade Agreement.

Here’s What’s in the New Nafta

There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada finalized in deadline-beating fashion on Sunday, starting with a name change.

October 2, 2018

The New York Times

There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada, starting with a name change.

Regulatory Labeling Guide: Toeing the Line With Confidence

September 26, 2018

Loftware

Optimize Traceability: 6 Best Practices in Packaging and Labeling to Improve Your Supply Chain

September 26, 2018

Loftware

Blockchain Hype May Finally Turn Into Reality in Pharmaceuticals

Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.

September 26, 2018

Bloomberg

Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.

Companies Stockpile Drugs, Chocolate as They Brace for ‘Hard’ Brexit

Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.

September 20, 2018

The Wall Street Journal

Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.

When Your Prescription Drug Is Tainted With a Chemical 'Used to Make Rocket Fuel'

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.

September 12, 2018

Los Angeles Times

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.

Hospitals Are Fed Up With Drug Companies, So They're Starting Their Own

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.

September 7, 2018

Los Angeles Times

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.